Tumor Mutational Burden (tmb) - Cancer Science

Relevant Publications

Recommendations for Tumor Mutational Burden Assay Validation and Reporting: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, and Society for Immunotherapy of Cancer.

Issue Release: 2024

Developing a prognostic model for skin melanoma based on the persistent tumor mutation burden and determining IL17REL as a therapeutic target.

Issue Release: 2024

Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small cell lung cancer.

Issue Release: 2024

Histopathological, Molecular and Clinical Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder (LELC-B).

Issue Release: 2024

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.

Issue Release: 2024

Comprehensive pan-cancer analysis reveals VSIR as a candidate immunologic, diagnostic, and prognostic biomarker.

Issue Release: 2024

The transcriptomic expression pattern of immune checkpoints shows heterogeneity between and within cancer types.

Issue Release: 2024

Molecular profiling of a bladder cancer with very high tumour mutational burden.

Issue Release: 2024

Efficacy and Safety of Programmed Death 1/Programmed Death-Ligand 1 Plus Cytotoxic T-Lymphocyte-Associated Antigen 4 Inhibitors for Advanced or Metastatic Non-Small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials.

Issue Release: 2024

Characterization of polyamine metabolism predicts prognosis, immune profile, and therapeutic efficacy in lung adenocarcinoma patients.

Issue Release: 2024

Development and validation of an interpretable radiomic signature for preoperative estimation of tumor mutational burden in lung adenocarcinoma.

Issue Release: 2024

A new gene signature associated with disulfidptosis that forecasts myasthenia gravis and suggests infiltration of immune microenvironment in thymoma patients.

Issue Release: 2024

Unveiling HOXB7 as a novel diagnostic and prognostic biomarker through pan-cancer computer screening.

Issue Release: 2024

Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma.

Issue Release: 2024

Integrating p53-associated genes and infiltrating immune cell characterization as a prognostic biomarker in multiple myeloma.

Issue Release: 2024

Identification of a lactate metabolism-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma.

Issue Release: 2024

Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios.

Issue Release: 2024

Clinicogenomic characterization of inflammatory breast cancer.

Issue Release: 2024

ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.

Issue Release: 2024

A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer.

Issue Release: 2024

What are the common risk factors for developing Cancer?

What Role Do Institutions Play in Promoting a Culture of Integrity?

What are the Implications of a High Tumor Grade?

What Types of Cancer Can Be Treated with Microsurgery?

How do direct medical costs impact cancer patients financially?

What is the Role of Genomic Sequencing in Cancer?

What Role Do Emergency Funds Play?

How Do Cancer Cells Interact with Their Microenvironment?

How is Biopython Useful in Cancer Research?

What is Aspergillus Parasiticus?

Tumor Mutational Burden (tmb) - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics